Time-dependent inhibition of PHD2
Isabelle Tcholakov1, Charles E Grimshaw2, Lihong Shi2
1In Vitro Pharmacology, Immunology, Takeda California, Inc., 10410 Science Center Drive, San Diego, CA 92121, U.S.A.
Bioscience Reports
|June 9, 2017
Summary
Small molecule inhibitors targeting prolyl hydroxylases (PHDs) show promise for anemia treatment. These compounds reversibly inhibit PHDs by competing with 2-oxoglutarate, acting as pan PHD inhibitors with long-lasting effects.
Area of Science:
- Biochemistry
- Pharmacology
- Cellular Biology
Background:
- Prolyl hydroxylases (PHDs) regulate hypoxia-inducible factors (HIFs) through proline residue hydroxylation, impacting cellular response to hypoxia.
- PHD inhibitors are under investigation for anemia treatment, with several in clinical trials.
Purpose of the Study:
- To perform detailed kinetic analysis of small molecule PHD inhibitors.
- To elucidate the mechanism of inhibition for these compounds.
Main Methods:
- Enzyme kinetics assays were performed to determine inhibition constants and mechanisms.
- Analysis included determination of co-substrate competition and time-dependent inhibition (TDI).
Main Results:
- The inhibitors were found to be reversible and competitive with 2-oxoglutarate (2-OG) at the enzyme active site.
- Most compounds acted as pan PHD inhibitors, affecting multiple PHD isoforms.
- A time-dependent inhibition (TDI) mechanism was observed, characterized by a slow dissociation rate constant (koff) and long residence time.
Conclusions:
- Small molecule PHD inhibitors exhibit competitive inhibition with 2-OG.
- The observed TDI mechanism suggests prolonged target engagement, potentially beneficial for therapeutic applications.
- These findings provide valuable kinetic insights for the development of PHD inhibitors for anemia.
Keywords:
hypoxiahypoxia inducible factorliquid chromatography-tandem mass spectrometryprolyl hydroxylase 2residence timetime-dependent inhibitionMore Related Videos
Related Concept Videos
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Feedback Inhibition
57.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.9K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Restarting Stalled Replication Forks
6.5K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.5K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K


